BBR Partners’s Edwards Lifesciences EW Stock Holding History

BBR Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,487	Closed	-$208K	–	204
2021 Q1	$208K	Buy	+2,487	New	+$210K	0.02%	196

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BBR Partners's EW Position: Q2 2021 in Review

BBR Partners sold out of Edwards Lifesciences (EW) in Q2 2021, closing a stake of 2,487 shares — an estimated $208K sold.

BBR Partners first reported a position in EW in Q1 2021 and held it in 1 quarter. The position peaked at $208K in Q1 2021. 1,188 funds tracked by Wall St. Rank hold EW as of Q2 2021.

BBR Partners reported no remaining Edwards Lifesciences position as of Q2 2021 after selling out during the quarter.
BBR Partners sold 2,487 Edwards Lifesciences shares in Q2 2021, an estimated $208K.
BBR Partners first reported a position in Edwards Lifesciences in Q1 2021 and held it in 1 quarter.
BBR Partners's Edwards Lifesciences position peaked at $208K in Q1 2021.
1,188 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on BBR Partners's 13F filing for Q2 2021, filed 13 Aug 2021.